Medexus Pharmaceuticals Inc.
MEDXF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $42,864 | $25,446 | $23,818 | $48,830 |
| - Cash | $23,973 | $5,255 | $13,069 | $10,018 |
| + Debt | $37,178 | $49,896 | $70,083 | $54,862 |
| Enterprise Value | $56,069 | $70,087 | $80,832 | $93,674 |
| Revenue | $108,332 | $113,054 | $108,096 | $76,701 |
| % Growth | -4.2% | 4.6% | 40.9% | – |
| Gross Profit | $56,584 | $59,514 | $60,038 | $37,927 |
| % Margin | 52.2% | 52.6% | 55.5% | 49.4% |
| EBITDA | $16,813 | $19,276 | $14,646 | $15,162 |
| % Margin | 15.5% | 17.1% | 13.5% | 19.8% |
| Net Income | $2,247 | -$214 | $1,221 | -$2,879 |
| % Margin | 2.1% | -0.2% | 1.1% | -3.8% |
| EPS Diluted | 0.082 | -0.01 | 0.06 | -0.14 |
| % Growth | 962.1% | -115.8% | 142.9% | – |
| Operating Cash Flow | $24,034 | $18,714 | -$1,444 | -$1,180 |
| Capital Expenditures | -$2,726 | -$266 | -$362 | -$7,714 |
| Free Cash Flow | $21,308 | $18,448 | -$1,806 | -$8,894 |